|Bid||0.9300 x 1000|
|Ask||0.9340 x 2900|
|Day's Range||0.9200 - 1.0400|
|52 Week Range||0.9200 - 13.7500|
|Beta (5Y Monthly)||1.46|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 10, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Jun 24, 2005|
|1y Target Est||9.50|
Subscribe to Yahoo Finance Plus to view Fair Value for BIOL
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been invited to participate in the 11th Annual Benchmark Discovery One-on-One Investor Conference taking place December 1, 2022 in New York City. President and Chief Executive Office, John Beaver, and Chief Financial Officer, Jennifer Bright, will host one-on-one meetings with investors and analysts during the event.
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the third quarter ended September 30, 2022.
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2022 financial and operating results on Thursday, November 10, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments.